Utilization of p53 and p16 Immunohistochemistry in the Classification of Human Papillomavirus–Associated, p53 Wild-Type, and p53 Abnormal Oral Epithelial …

R Novack, E Chapman, J Gao, B Horst, LN Hoang… - Modern Pathology, 2023 - Elsevier
Abstract p53 immunohistochemistry (IHC) has recently been shown to be a clinically useful
marker for predicting risk of progression to invasive squamous cell carcinoma in oral …
被引用次数：3 相关文章
[HTML] modernpathology.org

[HTML][HTML] Utilization of p53 and p16 Immunohistochemistry in the Classification of Human Papillomavirus–Associated, p53 Wild-Type, and p53 Abnormal Oral Epithelial …

R Novack, E Chapman, J Gao, B Horst… - Modern …, 2023 - modernpathology.org
Abstract p53 immunohistochemistry (IHC) has recently been shown to be a clinically useful
marker for predicting risk of progression to invasive squamous cell carcinoma in oral …

Utilization of p53 and p16 Immunohistochemistry in the Classification of HPV-Associated, p53 Wild-Type, and p53 Abnormal Oral Epithelial Dysplasia.

R Novack, E Chapman, J Gao, B Horst… - Modern Pathology: an …, 2023 - europepmc.org
p53 immunohistochemistry (IHC) has recently been shown to be a clinically useful marker
for predicting risk of progression to invasive squamous cell carcinoma in oral epithelial …
[HTML] modernpathology.org

[HTML][HTML] Utilization of p53 and p16 Immunohistochemistry in the Classification of Human Papillomavirus–Associated, p53 Wild-Type, and p53 Abnormal Oral Epithelial …

R Novack, E Chapman, J Gao, B Horst… - Modern …, 2023 - modernpathology.org
Abstract p53 immunohistochemistry (IHC) has recently been shown to be a clinically useful
marker for predicting risk of progression to invasive squamous cell carcinoma in oral …

Utilization of p53 and p16 Immunohistochemistry in the Classification of Human Papillomavirus-Associated, p53 Wild-Type, and p53 Abnormal Oral Epithelial …

R Novack, E Chapman, J Gao, B Horst… - … pathology: an official … - pubmed.ncbi.nlm.nih.gov
p53 immunohistochemistry (IHC) has recently been shown to be a clinically useful marker
for predicting risk of progression to invasive squamous cell carcinoma in oral epithelial …